331 related articles for article (PubMed ID: 27226562)
1. Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes.
Rajan MR; Nyman E; Kjølhede P; Cedersund G; Strålfors P
J Biol Chem; 2016 Jul; 291(30):15806-19. PubMed ID: 27226562
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FOXO1 transcription factor in primary human adipocytes mimics the insulin-resistant state of type 2 diabetes.
Rajan MR; Nyman E; Brännmark C; Olofsson CS; Strålfors P
Biochem J; 2018 May; 475(10):1807-1820. PubMed ID: 29724916
[TBL] [Abstract][Full Text] [Related]
3. A single mechanism can explain network-wide insulin resistance in adipocytes from obese patients with type 2 diabetes.
Nyman E; Rajan MR; Fagerholm S; Brännmark C; Cedersund G; Strålfors P
J Biol Chem; 2014 Nov; 289(48):33215-30. PubMed ID: 25320095
[TBL] [Abstract][Full Text] [Related]
4. Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.
Brännmark C; Nyman E; Fagerholm S; Bergenholm L; Ekstrand EM; Cedersund G; Strålfors P
J Biol Chem; 2013 Apr; 288(14):9867-9880. PubMed ID: 23400783
[TBL] [Abstract][Full Text] [Related]
5. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.
Ost A; Svensson K; Ruishalme I; Brännmark C; Franck N; Krook H; Sandström P; Kjolhede P; Strålfors P
Mol Med; 2010; 16(7-8):235-46. PubMed ID: 20386866
[TBL] [Abstract][Full Text] [Related]
6. Cross-talks via mTORC2 can explain enhanced activation in response to insulin in diabetic patients.
Magnusson R; Gustafsson M; Cedersund G; Strålfors P; Nyman E
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27986865
[TBL] [Abstract][Full Text] [Related]
7. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
Copps KD; Hançer NJ; Qiu W; White MF
J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
[TBL] [Abstract][Full Text] [Related]
8. Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes.
Kearney AL; Cooke KC; Norris DM; Zadoorian A; Krycer JR; Fazakerley DJ; Burchfield JG; James DE
J Biol Chem; 2019 Nov; 294(45):16729-16739. PubMed ID: 31548312
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes.
Pereira MJ; Palming J; Rizell M; Aureliano M; Carvalho E; Svensson MK; Eriksson JW
Mol Cell Endocrinol; 2012 May; 355(1):96-105. PubMed ID: 22333157
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H
PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor.
Gonzalez E; Flier E; Molle D; Accili D; McGraw TE
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10162-7. PubMed ID: 21646544
[TBL] [Abstract][Full Text] [Related]
13. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
Sajan MP; Ivey RA; Farese RV
Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.
Zhuang G; Yu K; Jiang Z; Chung A; Yao J; Ha C; Toy K; Soriano R; Haley B; Blackwood E; Sampath D; Bais C; Lill JR; Ferrara N
Sci Signal; 2013 Apr; 6(271):ra25. PubMed ID: 23592840
[TBL] [Abstract][Full Text] [Related]
16. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
17. PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway.
Chen L; Sun X; Xiao H; Xu F; Yang Y; Lin Z; Chen Z; Quan S; Huang H
Exp Cell Res; 2019 Aug; 381(2):301-310. PubMed ID: 31095939
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Death Dis; 2014 May; 5(5):e1214. PubMed ID: 24810050
[TBL] [Abstract][Full Text] [Related]
19. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
[TBL] [Abstract][Full Text] [Related]
20. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
